TLR4 triggers signaling cascades involving IκB phosphorylation and NF-κB-mediated inflammatory responses, which promotes hepatic fibrosis and drives MASLD progression to NASH and HCC [144]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.